42.2 C
Sunday, June 16, 2024

Avantor Life Sciences Acquires Masterflex for $2.9 Billion

Avantor Corporation, a supplier of ultrapure materials to the life sciences and high-tech industries, has agreed to acquire Masterflex’s bioprocessing business and related assets of Antylia Scientific, a life sciences instrument company, for $2.9 billion.

Masterflex is a US manufacturer of peristaltic pumps and single-use sterile fluid transfer technologies with estimated revenues of approximately $300 million in 2022. The acquisition strengthens Avantor’s offering in bioproduction products.

The all-cash transaction is valued at $2.9 billion, subject to final adjustments upon closing.

Given the expected tax benefits from the transaction structure, the net purchase price is approximately $2.7 billion.

The transaction is expected to be completed in the fourth quarter of 2021, and is subject to usual closing conditions, including receipt of applicable regulatory approvals.

HBC Editors
HBC Editorshttp://www.healthcarebusinessclub.com
HBC editors are a group of healthcare business professionals from diversified backgrounds. At HBC, we present the latest business news, tips, trending topics, interviews in healthcare business field, HBC editors are expanding day by day to cover most of the topics in the middle east and Africa, and other international regions.

Related Articles

Subscribe to our newsletter

Get notified about our latest news and articles. We are not spammy, we promise.

Latest Articles